Acne

Researchers found that the hemp derivative addressed multiple facets of acne pathophysiology and improved acne scarring overall.

A retrospective review found that sarecycline, a narrow-spectrum tetracycline, may be beneficial for patients with POD.

Patients with acne scarring who received concurrent therapy with isotretinoin and fractional radiofrequency achieved significant reductions in acne scar volume.

Hilary Baldwin, MD, presents a case study of a 17-year-old high school student with moderate acne vulgaris on her face and back, which caused significant emotional distress and lowered self-esteem, and discusses the patient's treatment journey and the resolution achieved.

Hilary Baldwin, MD, a dermatologist, presents a case study of a 12-year-old overweight male patient with a two-year history of moderate facial acne, discussing her diagnostic process and recommended treatment plan.

Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.

Continuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.

An expert dermatologist presents the case of a 17-year-old with moderate acne, and discusses the importance of the proper application layering of skin care and prescription products to optimize treatment efficacy.

Highlighting ways to maximize absorption of isotretinoin, Heather Woolery-Lloyd, MD, FAAD provides insights on dietary considerations and the role of micronized and food independent isotretinoin.

Heather Woolery-Lloyd, MD, FAAD reviews the case of a 12-year-old patient with moderate-to-severe acne, focusing on how to navigate appropriate treatment decisions and patient factors that indicate when a patient is an ideal candidate for isotretinoin.

The organization is highlighting stories and resources during Acne Awareness Month through the power of social media.

Supplementation with RGLE led to clinically significant improvements in patients with acne vulgaris, according to a study.

A new acne-specific HRQoL questionnaire developed in Europe could help to create more comprehensive, individualized treatment plans.

Acinonyx Bio's topical cream, ACX, targets Propionibacterium acnes.

Authors of a recent review concluded that combining various therapies holds promise in the treatment of acne scarring.

The awarded grant will span a total of 3 years.

Aaron Farberg, MD, discusses the low-dose, affordable Accutane treatment and Clear Health’s mission to improve patient access to affordable acne therapies.

From our April cover feature: Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD.

Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.

Over 50% of women in their 20s and over 35% of women aged 30 to 39 years struggle with adult female cystic acne.

The statement said the petition came as a surprise to many ahead of AAD, and delves into the data complexity and patient considerations.

In this week’s Pointers With Portela, the 208SkinDoc dives into the efficacy and adverse effects of generic vitamin A to treat acne.

On March 6, 2024, Valisure, an independent testing laboratory, found high levels of benzene when BPO products were incubated at 37°C, 50°C, and 70°C.

Tween skin care has become a rising trend across social media platforms such as TikTok, and dermatology clinicians are becoming increasingly concerned about misinformation.

Christopher Bunick, MD, PhD, presented updates and new data on the recent news of benzene found in benzoyl peroxide products.